KAL ELHOREGY, Director, Risk Evaluation and Mitigation Strategy (REMS) Programs, Amneal Pharmaceuticals

•   Kal Elhoregy is an accomplished healthcare industry executive with 24+ years’ experience focused on implementation of Risk Minimization Programs, Quality Management Systems (QMS) and Pharmacovigilance (PV) Compliance within the pharmaceutical industry. In his current role as a Director, Risk Evaluation and Mitigation Strategy (REMS), Regulatory Affairs Clinical at Amneal Pharmaceuticals, he manages all risk management programs and ensures the entity’s full compliance with risk management standards and guidelines.

•   As a strategist and accessible leader with experience in PV & Quality Risk Management (QRM), he helped multiple disciplines to effectively manage compliance risk in accordance with regulatory guidelines and increasing organizational capacity through streamlining complex processes.

•   He is a registered and licensed Pharmacist and holds a Bachelor of Science, Accounting from the Faculty of Commerce, Ain Shams University and Bachelor of Science of Pharmacy from Arnold & Marie Schwartz College of Pharmacy, Long Island University, New York.
His experience within the Health Care settings as a lead infusion Pharmacist, including Pediatric Intensive Care Units and Critical Care Unit Pharmacies. Also, his experience within the Pharmaceutical industry includes a strong expertise and leadership in PV Compliance, QRM and Quality System of PV, REMS, Risk Management Plan (RMP), GVP / CSV Risk Based Audit and Inspection Readiness.

•   Kal believes in leadership and teamwork and focuses on what is important to achieve successful results in ensuring patient safety and regulatory compliance.